In high grade or advanced ovarian cancer, high numbers of FoxP3+ Tregs infiltrating were found to be associated with improved survival, whereas the pooled analyses of the remaining studies showed FoxP3+ Tregs were associated with poor prognosis. Here, FOXP3 is linked to ovarian carcinoma.